Dupilumab for COPD with Type 2 Inflammation Indicated by Eosinophil CountsSurya P. Bhatt, Raolat M. Abdulai, Stephanie A. Christenson et al.|New England Journal of Medicine|2023Cited by 452
Dupilumab for COPD with Blood Eosinophil Evidence of Type 2 InflammationSurya P. Bhatt, Lacey B. Robinson, Klaus F. Rabe et al.|New England Journal of Medicine|2024Cited by 240
An Undergraduate Laboratory Series Using C. elegans That Prepares Students for Independent InquiryVirginia Quinan, Déborah Bauer|Journal of Undergraduate Neuroscience Education|2023Cited by 1